April 8 (Reuters) - President Donald Trump on Tuesday said the U.S. will soon announce a "major" tariff on pharmaceutical imports. Speaking to an event at the National Republican Congressional ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

Apr. 1, 2025 — A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and ... Could an Arthritis Drug Unlock ...

Prime Minister Anthony Albanese has again vowed to never negotiate on the Pharmaceutical Benefits Scheme in discussions with the United States on tariffs. Meanwhile, Peter Dutton has officially ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, let’s get straight into all the news today. In his ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

American medical giants have written to the Trump administration, urging it to consider Australia's Pharmaceutical Benefits Scheme as an "unfair trade practice" and to impose "reciprocal" tariffs.

Governments and employers worldwide have expanded access to care. Yet pharmaceutical innovation hasn’t kept pace. Since the blockbuster success of drugs such as Prozac and Zoloft in the 1990s ...

Sustainabilitycategory Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy April 10, 2025 category US measles battle hindered by confusion over health ...

CHATHAM, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...

2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception. The industry is grappling with significant market shifts amidst emerging ...